An observational study in Sepsis, sponsored by University Hospital, Basel, Switzerland. Recruiting at 16 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-05.
Sponsored by University Hospital, Basel, Switzerland · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Sepsis by University Hospital, Basel, Switzerland — 2 open to participants now, 2 under way, none of them phase 3. Sepsis · University Hospital, Basel, Switzerland.
Among the 11 studies in Sepsis by University Hospital, Basel, Switzerland, this one is one of 2 that started in 2019, is one of 8 observational ones, and was the 5th registered.
2,425 studies on the registry are indexed under Sepsis; 543 are open to participants now.
Browse Sepsis studies →2 of the 11 studies in Sepsis by University Hospital, Basel, Switzerland are open now, in 1 country. Recruiting first, the newest first:
University Hospital, Basel, Switzerland · Sites in Switzerland
Ages 18+
By country, each count listing its studies:
Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2019.
This study's planned enrollment of 17,500 is above the median of 150 across 1,166 observational studies indexed under Sepsis.
Median enrollment 231 across the 3 interventional studies, 283 across the 8 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Hospital, Basel, Switzerland is the lead sponsor of 990 studies on the registry; 189 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 11 studies in Sepsis by University Hospital, Basel, Switzerland, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This multi-center study is to focus on patients with sepsis in Intensive Care Units (ICUs) in order to better understand the complex host-pathogen interaction and clinical heterogeneity associated with sepsis. Understanding this heterogeneity may allow the development of novel diagnostic approaches. Data from patients will be analyzed using state-of-the art analytical algorithms for biomarker discovery including machine learning and multidimensional mathematical modelling to explore the large datasets generated. In order to discover digital biomarkers for the study endpoints a case-control study design will be used to compare data patterns from patients with sepsis (cases) and those without sepsis (controls).
ICU patients on a Swiss University Hospital ICU from 01.08.2019
Inclusion Criteria:
Inclusion Criteria (cases)
Inclusion Criteria (controls)
Exclusion Criteria:
patients who developed or were admitted with sepsis to the ICU (cases)
Other: compare data patterns by data-driven algorithms to determine sepsis · Other: compare data patterns by data-driven algorithms to predict sepsis-related mortality
patients who did not develop sepsis (controls).
Other: compare data patterns by data-driven algorithms to determine sepsis · Other: compare data patterns by data-driven algorithms to predict sepsis-related mortality
compare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to reliably determine sepsis
compare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to to predict sepsis-related mortality
sepsis-related mortality (sensitivity)
Algorithm to predict sepsis-related mortality (sensitivity)
Time frame: time- series data collected from hospital entry until maximum 12 months after hospital exit (no exact time point specified)
sepsis-related mortality (specificity)
Algorithm to predict sepsis-related mortality (specificity)
Time frame: time- series data collected from hospital entry until maximum 12 months after hospital exit (no exact time point specified)
Determination of sepsis
Algorithm to determine sepsis at an early stage (at least 12 hours before classical definitions)
Time frame: time- series data collected from hospital entry until hospital exit; an average of 1 month (no exact time point specified)
Ran from Nov 2019 to primary completion in May 2022, 30 months.
Of 496 non-industry observational studies under Sepsis, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 57. This study's 30 months is close to that.
Counting every sponsor, half of 548 studies reached it within 27 months; a quarter within 12 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Basel, Switzerland →